Herantis Pharma

Herantis Pharma Plc

Company release 20 June 2023 at 10:30 EEST

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Frans Wuite

Position: Member of the Board/Deputy member

 Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 33786/4/4

____________________________________________

Transaction date: 2023-06-16

Outside a trading venue

Instrument type: SHARE

ISIN: FI4000087861

Nature of transaction: EXERCISE OF A STOCK OPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 1600 Unit price: 0.00005 EUR

Aggregated transactions (1):

Volume: 1600 Volume weighted average price: 0.00005 EUR

____________________________________________

Further information:

Julie Silber/Gabriela Urquilla

Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19

Email:ir@herantis.com

Certified Advisor: UB Securities Ltd, +358 9 25 380 225

Company website: www.herantis.com

Distribution:

Main media
www.herantis.com